Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Keri Hannagan"'
Autor:
Kelly M. Harrington, Matthew H. Liang, Keri Hannagan, Soe Soe Thwin, Ryan E. Ferguson, Natalie Morgenstern, Erick Flores, Ira R. Katz
Publikováno v:
Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 149-154 (2016)
Background: The estimation of an effect size is an important step in designing an adequately powered, feasible clinical trial intended to change clinical practice. During the planning phase of VA Cooperative Study #590, “Double-Blind Placebo-Contro
Externí odkaz:
https://doaj.org/article/abb60b29ba7640768245296dda0149f6
Autor:
Erick Flores, Keri Hannagan, Natalie Morgenstern, Ryan Ferguson, Matthew H. Liang, Soe Soe Thwin, Ira R. Katz, Kelly M. Harrington
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 149-154 (2016)
Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 149-154 (2016)
Background The estimation of an effect size is an important step in designing an adequately powered, feasible clinical trial intended to change clinical practice. During the planning phase of VA Cooperative Study #590, “Double-Blind Placebo-Control
Autor:
Kelly M. Harrington, Xuan-Mai T. Nguyen, Rebecca J. Song, Keri Hannagan, Rachel Quaden, David R. Gagnon, Kelly Cho, Jennifer E. Deen, Sumitra Muralidhar, Timothy J. O’Leary, John Michael Gaziano, Stacey B. Whitbourne, J. Michael Gaziano, Rachel Ramoni, Jim Breeling, Kyong-Mi Chang, Grant Huang, Christopher J. O’Donnell, Philip S. Tsao, Jennifer Moser, Jessica V. Brewer, John Concato, Stuart Warren, Pharm D, Dean P. Argyres, Brady Stephens, Mary T. Brophy, Donald E. Humphries, Nhan Do, Shahpoor Shayan, Saiju Pyarajan, Elizabeth Hauser, Yan Sun, Hongyu Zhao, Peter Wilson, Rachel McArdle, Louis Dellitalia, John Harley, Jeffrey Whittle, Jean Beckham, John Wells, Salvador Gutierrez, Gretchen Gibson, Laurence Kaminsky, Gerardo Villareal, Scott Kinlay, Junzhe Xu, Mark Hamner, Kathlyn Sue Haddock, Sujata Bhushan, Pran Iruvanti, Michael Godschalk, Zuhair Ballas, Malcolm Buford, Stephen Mastorides, Jon Klein, Nora Ratcliffe, Hermes Florez, Alan Swann, Maureen Murdoch, Peruvemba Sriram, Shing Shing Yeh, Ronald Washburn, Darshana Jhala, Samuel Aguayo, David Cohen, Satish Sharma, John Callaghan, Kris Ann Oursler, Mary Whooley, Sunil Ahuja, Amparo Gutierrez, Ronald Schifman, Jennifer Greco, Michael Rauchman, Richard Servatius, Mary Oehlert, Agnes Wallbom, Ronald Fernando, Timothy Morgan, Todd Stapley, Scott Sherman, Gwenevere Anderson, Philip Tsao, Elif Sonel, Edward Boyko, Laurence Meyer, Samir Gupta, Joseph Fayad, Adriana Hung, Jack Lichy, Robin Hurley, Brooks Robey, Robert Striker
Publikováno v:
Womens Health Issues
Background The Department of Veterans Affairs Million Veteran Program (MVP) is the largest ongoing cohort program of its kind, with 654,903 enrollees as of June 2018. The objectives of this study were to examine gender differences in the MVP cohort w
Autor:
Joanne Valeriano-Marcet, Amy Joseph, Ted R. Mikuls, J. Rodrigues, Thomas Olenginski, Cynthia Weaver, Salahuddin Kazi, Pamela E. Prete, Ciaran S. Phibbs, James R. O'Dell, Peter D. Kent, Keri Hannagan, Samardeep Gupta, Jay E. Persselin, Keith K. Colburn, Erika Holmberg, Virginia Reddy, David I. Daikh, Joseph Fanciullo, Liam Martin, Gail S. Kerr, Aslam H. Anis, Lynne Peterson, Sarah Leatherman, Karen S. Kolba, Hani El-Gabalawy, Raymond Hausch, Andrew Chow, Andreas M. Reimold, Vivian P. Bykerk, William T. Ayoub, Huiying Sun, Gilles Boire, John M. Davis, David Pugliese, H. Ralph Schumacher, Edward C. Keystone, Mary Brophy, Mahfooz Peshimam, C. Kent Kwoh, Jennifer R. Elliott, J. Carter Thorne, Maren L. Mahowald, Nick Bansback
Publikováno v:
Annals of internal medicine. 167(1)
The RACAT (Rheumatoid Arthritis Comparison of Active Therapies) trial found triple therapy to be noninferior to etanercept-methotrexate in patients with active rheumatoid arthritis (RA).To determine the cost-effectiveness of etanercept-methotrexate v
Autor:
Aslam H. Anis, Keri Hannagan, Edward C. Keystone, Ciaran S. Phibbs, Mary Brophy, James R O’Dell, Nick Bansback
Publikováno v:
Trials
A recent trial in rheumatoid arthritis found an inexpensive, but infrequently used, combination of therapies is neither inferior nor less safe than an expensive biologic drug. If the trial had been conducted over 10 years ago, arguably 100’s of mil
Publikováno v:
Rheumatology. :kew412
Objective. The main aim of this study was to examine the differences between triple therapy (T: SSZ and HCQ added to MTX) and etanercept (E) added to MTX with regard to the infectious and gastrointestinal (GI) adverse events (AEs) reported in The Rhe
Autor:
Susan Lin, Keri Hannagan, Sheila J. McMurrich, Katie Weinger, A. Enrique Caballero, Arlene Smaldone, Om P. Ganda
Publikováno v:
Diabetes care. 29(7)
Although the rising prevalence of type 2 diabetes and economic factors have resulted in more group diabetes education (1–4), little research has examined the effective use of group education or composition of groups. Regardless of group or individu